4 results on '"Kimbria J. Blake"'
Search Results
2. Neuronal Regulation of Immunity in the Skin and Lungs
- Author
-
Isaac M. Chiu, Xin Ru Jiang, and Kimbria J. Blake
- Subjects
0301 basic medicine ,Nervous system ,Neuroimmunomodulation ,Neuropeptide ,Inflammation ,Article ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Immunity ,medicine ,Animals ,Humans ,Lung ,Skin ,business.industry ,General Neuroscience ,Atopic dermatitis ,medicine.disease ,030104 developmental biology ,Neuroimmunology ,medicine.anatomical_structure ,Immunology ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Homeostasis - Abstract
The nervous and immune systems are classically studied as two separate entities. However, their interactions are crucial for maintaining barrier functions at tissues constantly exposed to the external environment. We focus here on the role of neuronal signaling in regulating the immune system at two major barriers: the skin and respiratory tract. Barrier tissues are heavily innervated by sensory and autonomic nerves, and are densely populated by resident immune cells, allowing rapid, coordinated responses to noxious stimuli, as well as to bacterial and fungal pathogens. Neural release of neurotransmitters and neuropeptides allows fast communication with immune cells and their recruitment. In addition to maintaining homeostasis and fighting infections, neuroimmune interactions are also implicated in several chronic inflammatory conditions such as atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and asthma.
- Published
- 2019
3. On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis
- Author
-
Isaac M. Chiu, T.C. Lynn, María Teresa García-Romero, Jean C. Lee, Felix M. Key, Tami D. Lieberman, Khadka Vd, Liwen Deng, C. Romo-González, and Kimbria J. Blake
- Subjects
Disease ,Atopic dermatitis ,Biology ,medicine.disease ,medicine.disease_cause ,Microbiology ,Asymptomatic ,Staphylococcus aureus ,Virology ,Genotype ,Immunology ,medicine ,Parasitology ,Colonization ,Microbiome ,medicine.symptom ,Gene - Abstract
Genetic variation among bacterial strains can contribute to heterogeneity in the severity of chronic inflammatory diseases 1,2, but the degree of variation created by de novo mutation during colonization is not well understood. The inflamed skin of people with atopic dermatitis (AD) is frequently colonized with Staphylococcus aureus, an opportunistic pathogen associated with both asymptomatic colonization of nasal passages and invasive disease 3–6. While genetic risk and barrier disruption are critical to AD initiation 7,8, S. aureus colonization is thought to worsen disease severity by promoting skin damage9 1,4,5,10. Here we show, from tracking 23 children treated for AD over 9 months, that S. aureus adapts via de novo mutations during colonization. Patients’ S. aureus populations are typically dominated by a single lineage, with infrequent invasion by distant lineages. Variants emerge within each lineage with mutation accumulation rates similar to S. aureus in other contexts. Some of these variants replace their ancestors across the body within months, with signatures of adaptive, rather than neutral, forces. Most strikingly, the capsule synthesis gene capD obtained four parallel mutations within one patient and was involved in mutational sweeps in multiple patients. We confirm that selection for capD negativity is common in AD, but not in other contexts, via reanalysis of public S. aureus genomes from 276 people. Our finding of disease-specific selection raises the possibility that adaptation of pathobionts during colonization prolongs the positive feedback cycle of inflammation.
- Published
- 2021
4. Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314
- Author
-
Michael Otto, Kelsey L. Adams, Ashira Lubkin, Victor J. Torres, David Roberson, Kimbria J. Blake, Clifford J. Woolf, Tiphaine Voisin, Yuxin C. Ma, Isaac M. Chiu, Felipe A. Pinho-Ribeiro, and Pankaj Baral
- Subjects
Methicillin-Resistant Staphylococcus aureus ,0301 basic medicine ,Science ,Bacterial Toxins ,Analgesic ,TRPV1 ,Leukocidin ,Pain ,TRPV Cation Channels ,General Physics and Astronomy ,Pharmacology ,medicine.disease_cause ,Article ,General Biochemistry, Genetics and Molecular Biology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Sodium channel blocker ,medicine ,Animals ,Anesthetics, Local ,lcsh:Science ,Pathogen ,Neurons ,Multidisciplinary ,business.industry ,fungi ,Lidocaine ,food and beverages ,General Chemistry ,Staphylococcal Infections ,Ibuprofen ,3. Good health ,Mice, Inbred C57BL ,030104 developmental biology ,Staphylococcus aureus ,Gene Knockdown Techniques ,Nociceptor ,lcsh:Q ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
The hallmark of many bacterial infections is pain. The underlying mechanisms of pain during live pathogen invasion are not well understood. Here, we elucidate key molecular mechanisms of pain produced during live methicillin-resistant Staphylococcus aureus (MRSA) infection. We show that spontaneous pain is dependent on the virulence determinant agr and bacterial pore-forming toxins (PFTs). The cation channel, TRPV1, mediated heat hyperalgesia as a distinct pain modality. Three classes of PFTs—alpha-hemolysin (Hla), phenol-soluble modulins (PSMs), and the leukocidin HlgAB—directly induced neuronal firing and produced spontaneous pain. From these mechanisms, we hypothesized that pores formed in neurons would allow entry of the membrane-impermeable sodium channel blocker QX-314 into nociceptors to silence pain during infection. QX-314 induced immediate and long-lasting blockade of pain caused by MRSA infection, significantly more than lidocaine or ibuprofen, two widely used clinical analgesic treatments., Bacterial infection can cause pain but the underlying mechanism is unclear. This study shows pain induced in mice by methicillin-resistant Staphylococcus aureus infection is mediated by bacterial pore-forming toxins, and a sodium channel blocker QX-314 can alleviate infection-associated pain.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.